BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives (Q33644841)

28 July 2017

1 reference

title

BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives (English)

1 reference

28 July 2017

0 references

2

M J Khoury

1 reference

28 July 2017

S S Coughlin

1

1 reference

PubMed ID

10343884

28 July 2017

K K Steinberg

series ordinal

3

1 reference

28 July 2017

1 February 1999

1 reference

American Journal of Preventive Medicine

28 July 2017

1 reference

28 July 2017

16

1 reference

28 July 2017

2

1 reference

28 July 2017

91-98

1 reference

Linkage of early-onset familial breast cancer to chromosome 17q21

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Pitfalls of genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

BRCA1--lots of mutations, lots of dilemmas

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The rapid detection of unknown mutations in nucleic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Inherited breast and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The association of age and familial risk in a case-control study of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Genetic epidemiology of breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Family history of breast cancer as a risk indicator for the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Genetic heterogeneity in breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Mutations of the BRCA1 gene in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Genetic alterations in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Inherited breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Breast and other cancers in families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Growing pains for the environmental genetics of breast cancer: observations on a study of the glutathione S-transferases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

A common BRCA1 mutation in the Ashkenazim.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

BRCA1 mutations in young women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Testing for the breast cancer predisposition gene, BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Risk modifiers in carriers of brca1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Informed consent for genetic research on stored tissue samples

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Quantitating familial cancer risk: a resource for clinical oncologists

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent

1 reference

https://api.crossref.org/works/10.1016%2FS0749-3797%2898%2900136-6

7 January 2021

10.1016/S0749-3797(98)00136-6

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10343884